Necrotizing Enterocolitis after Octreotide Treatment in a Preterm Newborn with Idiopathic Congenital Chylothorax

Mehmet Büyüktiryaki, Mehmet Yekta Oncel, Nilufer Okur, Turan Derme, Serife Suna Oguz


Octreotide, a somatostatin analogue, has been used for the management of patients with refractory chylothorax. Side effects related to the gastrointestinal system associated with octreotide are necrotizing enterocolitis (NEC) and focal intestinal perforation. NEC is the most common and dangerous gastrointestinal emergency in premature infants. We present the development of necrotizing enterocolitis after octreotide treatment in a preterm infant with idiopathic congenital chylothorax which settled after discontinuation of octreotide.


Congenital chylothorax; Octreotide; Necrotizing enterocolitis; Preterm

Full Text:

html PDF



  • There are currently no refbacks.

Copyright (c) 2017 Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2218-8185

We are now in process to use new version of Open Journal System. Submission are now open on our new website. Please CLICK HERE to divert to our new manuscript management system. You are required to register an author account before making any submission.